SHL brings innovation to Pharmapack Europe 2017

pharmafile | January 10, 2017 | News story | Manufacturing and Production, Research and Development, Sales and Marketing auto injector, connectivity, delivery devices, smart packaging 

As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow.

This February, SHL will show a full range of drug delivery devices including time-tested solutions in disposable auto injectors and pen injectors. At the center of attention will be the innovative auto injector platform – Molly®. From higher volume to connectivity, Molly devices can accommodate a wide range of requirements from our biopharmaceutical and pharma partners.

Another highlight of this year’s exhibition – high viscosity devices – will be available for demonstration.  SHL representatives will be happy to discuss these devices along with other services and capabilities available through our comprehensive network, including development, manufacturing and commercialization solutions.

Digital technology in pharmaceutical packaging is in the focus of this year’s conference. SHL will showcase our latest development in the area of smart packaging – FlexRec for multi-medication tracking. FlexRec blister pack is a concept developed by SHL in cooperation with Nelipak, a leading manufacturer of custom thermoformed healthcare packaging. This new system enables increasingly smart and simple medication tracking and adherence improvement.

We are proud to announce that our most recent device add-on solution – the ENYA Platform developed in partnership with Innovation Zed Ltd. – will be displayed in the Innovation Gallery and competing for Pharmapack Europe Awards. ENYA is an innovative device, a smart add-on offering which automatically tracks injection pen usage ‘on the go’, without user input. Find out more about possibilities opened up by add-on platforms through Innovation Tours or come and ask us directly!

Join us in Paris for Pharmapack Europe 2017 at booth #H44 to learn more about our devices, packaging solutions and innovative offers.

About SHL

SHL is one of the world’s largest solution providers in design, development and manufacturing of advanced drug delivery devices such as auto injectors and pen injectors. With locations in Taiwan, Sweden and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.

With over 3,500 staff worldwide, our organization consists of several distinct group companies:

SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies

SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use

SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products

SHL Pharma
Provides final assembly, labeling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries

For additional information visit www.shl-group.com or contact us at info@shl-group.com

SHL Media Contact:
Alina Smotrova

PR&Communications

+886 32170303

alina.smotrova@shl-group.com

 

About Nelipak® Healthcare Packaging

Nelipak® Healthcare Packaging designs, develops and manufactures custom thermoformed packaging products that provide superior protection for medical devices and pharmaceuticals.  The company offers medical trays and blisters, surgical procedure trays, pharmaceutical handling trays, custom built sealing machines, total packaging solutions and other value added services.  Some of the largest and most reputable medical device and pharmaceutical companies in the world rely on Nelipak’s 60-year history of innovation in cleanroom manufactured thermoformed medical packaging.

With facilities in Cranston, RI; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Juncos, Puerto Rico; and San Jose, Costa Rica, and more than 600 employees worldwide, Nelipak is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations. More information about Nelipak can be found at http://www.nelipak.com.

Nelipak® Healthcare Packaging is a trade name of Nelipak® Corporation.

Follow us on:

Twitter: www.twitter.com/nelipak1953

LinkedIn: https://www.linkedin.com/company/nelipak

YouTube: www.youtube.com/user/nelipakhealthcare

Marketing Contact:

Seán Egan

Group Marketing Manager

Nelipak Healthcare Packaging

+353-91-709-163

Sean.egan@nelipak.com

 

About Innovation Zed Ltd.

Innovation Zed Ltd. is a Research and Development Company based in Ireland with a focus on ‘’connected health’ solutions and services in Drug Adherence and Condition Management.

Based at the innovation hub of University College Dublin, one of the leading research intensive universities with a flourishing history extending well over 160 years, Innovation Zed has access to a vast array of industry expertise including ICT, biotech, medical devices, wireless technology and renewable energy.

 

For additional information visit www.innovationzed.com or contact us at info@innovationzed.com

Related Content

novartis_outside_1

Novartis secures US rights to Adamis’ epinephrine auto injector

Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine …

scott_gottlieb

FDA unveils guidelines to help generic medical device versions reach the market

The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of …

teva_copy

Teva suffers EpiPen generic setback after FDA rejection

The release of Teva Pharmaceuticals generic for the anaphylaxis treatment, EpiPen (epinephrine), is now expected …

Latest content